BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16829703)

  • 1. Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years.
    Sato K; Shiga T; Matsuda N; Onoda N; Takano K; Hagiwara N; Kasanuki H
    Endocr J; 2006 Aug; 53(4):531-8. PubMed ID: 16829703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
    Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
    Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone-induced thyrotoxicosis in children and adolescents is a possible outcome in patients with low iodine intake.
    Hacihamdioğlu B; Berberoğlu M; Siklar Z; Savaş Erdeve S; Oçal G; Tutar E; Atalay S
    J Pediatr Endocrinol Metab; 2010 Apr; 23(4):363-8. PubMed ID: 20583541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-Induced Thyrotoxicosis Recurrence After Amiodarone Reintroduction.
    Maqdasy S; Batisse-Lignier M; Auclair C; Desbiez F; Citron B; Thieblot P; Roche B; Lusson JR; Tauveron I
    Am J Cardiol; 2016 Apr; 117(7):1112-6. PubMed ID: 26853955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature.
    Maqdasy S; Benichou T; Dallel S; Roche B; Desbiez F; Montanier N; Batisse-Lignier M; Tauveron I
    Ann Endocrinol (Paris); 2019 Feb; 80(1):54-60. PubMed ID: 30236455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias.
    Hermida JS; Tcheng E; Jarry G; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C
    Europace; 2004 Mar; 6(2):169-74. PubMed ID: 15018878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
    Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
    Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody.
    Sato K; Yamazaki K; Kanaji Y; Ohnishi S; Kasanuki H; Demura H
    Thyroid; 1998 Dec; 8(12):1123-6. PubMed ID: 9920368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of amiodarone-induced thyrotoxicosis.
    Osman F; Franklyn JA; Sheppard MC; Gammage MD
    Circulation; 2002 Mar; 105(11):1275-7. PubMed ID: 11901034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Challenges in the management of amiodarone-induced thyrotoxicosis].
    Tauveron I; Batisse-Lignier M; Maqdasy S
    Presse Med; 2018 Sep; 47(9):746-756. PubMed ID: 30274916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone-induced thyroid dysfunction.
    Danzi S; Klein I
    J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
    O'Sullivan AJ; Lewis M; Diamond T
    Eur J Endocrinol; 2006 Apr; 154(4):533-6. PubMed ID: 16556715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone-induced thyrotoxicosis suggestive of thyroid damage.
    Lambert M; Unger J; De Nayer P; Brohet C; Gangji D
    J Endocrinol Invest; 1990 Jun; 13(6):527-30. PubMed ID: 2258582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis.
    Campi I; Perego GB; Ravogli A; Groppelli A; Parati G; Persani L; Fugazzola L
    Eur J Endocrinol; 2019 Nov; 181(5):519-524. PubMed ID: 31536966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
    Gerber H; Noth D
    Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone-induced thyrotoxicosis late after amiodarone withdrawal.
    Yagishita A; Hachiya H; Kawabata M; Nakamura T; Sugiyama K; Tanaka Y; Sasano T; Isobe M; Hirao K
    Circ J; 2013; 77(12):2898-903. PubMed ID: 24042320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: a prospective, randomized study.
    Bogazzi F; Bartalena L; Cosci C; Brogioni S; Dell'Unto E; Grasso L; Aghini-Lombardi F; Rossi G; Pinchera A; Braverman LE; Martino E
    J Clin Endocrinol Metab; 2003 May; 88(5):1999-2002. PubMed ID: 12727944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone and thyroid dysfunction.
    Padmanabhan H
    South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amiodarone treatment and thyroid disorders].
    Łacka K; Fraczek MM
    Pol Merkur Lekarski; 2013 Jul; 35(205):5-9. PubMed ID: 23984597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.